Home Analyst Ratings Piper Sandler raises DocuSign Inc. ’s rating to Overweight and price target...

Piper Sandler raises DocuSign Inc. [DOCU]’s rating to Overweight and price target to $300

Piper Sandler took its DocuSign [DOCU] rating to the equivalent of Overweight from Neutral, and the ‎price target to 300.0, in a research note dated 2021-01-05. That figure represents around a 34.89% ‎premium from where the company’s shares closed on Monday. Some new analysts also started their ‎coverage, with Needham’s analysts assigning the shares to “a Buy” rating in a research note to ‎investors issued in mid November. Meanwhile, Robert W. Baird had launched its coverage on DOCU ‎with “an Outperform”, in a research note produced for clients October 27, 2020. In addition, UBS ‎launched coverage on October 14, 2020. The research firm rated DOCU “a Buy”.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Is DocuSign Inc. [NASDAQ:DOCU] a Good Buy ‎Right Now?

It should be noted that DOCU technical indicators for short, intermediate as well as ‎long term progress have placed an overall average of 72% as Buy. The average signal changed from ‎‎100% Buy in the last week and compares with 56% Buy in the past month. Data from DocuSign Inc.’s ‎Trend Spotter indicated that the signals were Weakening. The stock current average is 3.9 million ‎shares in the past 20 days and the short term average signal indicates a 50% Buy. In the last 50 days, ‎the average trading volume was 3.76 million shares while the medium term average advocated for 50% ‎Buy. The average long-term signal stands at 100% Buy and the 100-day average volume stands at 4.99 ‎million shares.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


DOCU Price Performance

On Wall Street, DocuSign Inc. [NASDAQ:DOCU] ‎finished Monday’s session up 0.05% at $222.41. The stock went up to $224.625 at the same session ‎while its lowest single day price was $216.50. In the last five days, it saw a fall of about -9.19%, ‎DocuSign Inc. shares gained by almost 0.05% since the beginning of the year. However, the share price ‎has dropped to as low as -23.37% below its one year high. On 01/04/21, the company shares recorded ‎‎$224.63, the highest single-day price it has got to in the last 52-weeks and a 52-week low was seen on ‎‎01/04/21, the same year at $216.50. The company’s shares have inclined by 194.35% in the past year. ‎The 50-day SMA achieved is $223.68 while the 200-day SMA is $182.49. Volume gained to 2.76 million ‎from 2.21 million in the previous session.

DOCU Stock Support And Resistance Levels

On the ‎‎24-hour scale, the immediate backing is perceived around 217.73 level, and in case of violation of this ‎particular level, it will cause more drop to 213.05 level. On the upper level, 229.30 is still the key ‎resistance. The stock may increase to the subsequent resistance at 225.86. The Relative Strength Index ‎‎(RSI) pinned on the 14-day chart is 44.28, implying a neutral technical stance while the MACD stands at ‎‎-12.44, meaning price will decrease in the next trading period. Percent R indicator moved to 83.71%, ‎implying bearish price movement. Stochastic %K at 8.95% suggest selling the stock.

What is the ‎short interest in DocuSign Inc.?

Short interest in the DocuSign Inc. stock has surged, increasing by ‎‎1.13 million shares to total 7.98 million shares on Dec 14, 2020. The interest had seen shares on Nov 12, ‎‎2020 stand at 9.11 million, data from Yahoo Finance shows. The decrease of -14.16% suggests the stock ‎saw some decreased bullish sentiment. The stock’s days to cover (short ratio) moved to while the ‎shorted shares account for just 5.07% of the overall float for the stock.

DocuSign Inc.’s Biggest ‎Shareholders: Who Owns DocuSign Inc. [DOCU]?

Filings by The Vanguard Group, Inc. showed ‎that the firm now holds a total of 15,828,618 shares or roughly 8.55% of the outstanding DOCU shares. ‎This means their shares have increased by 295,393 from the 15,828,618 the investor reportedly held in ‎its prior 13-F filing. With the conclusion of the purchase, T. Rowe Price Associates, Inc. updated stake is ‎worth $3,240,787,672. Details in the latest 13F filings reveal that BlackRock Fund Advisors acquired their ‎‎10.71% stake valued at $1,888,453,410. During the last quarter, BlackRock Fund Advisors raised 801,398 ‎of its shares in DocuSign Inc. while Lone Pine Capital LLC bought 4,135,353 shares. The SSgA Funds ‎Management, Inc.’s holdings currently number 3,667,014 shares at $815580583.74. According to the ‎firm’s last 13F report, Franklin Advisers, Inc. shares in the company at filing stood at 2,524,923 shares, ‎roughly $575,379,453.

DOCU Earnings Forecast For The Current Quarter

DocuSign Inc. ‎‎[DOCU] is expected to report strong earnings results for the quarter ending on Jan 2021. Consensus ‎estimates give the company expected revenues of $407.58M and an earnings per share of $0.22 for ‎Jan 2021. Looking further ahead, the company is expected to report revenue of $410.03M at an EPS of ‎‎$0.21 for Apr 2021. The estimates represent upside of 30.20% and 50.61% in the company’s revenue ‎and earnings per share, respectively, on a year-on-year basis.

Get the ‎hottest stocks to trade every day before the market opens 100% free. Click here ‎now. 

DOCU Earnings Estimates For The Current Year

For the ‎financial year, DocuSign Inc. [NASDAQ:DOCU] is expected to bring in revenue of $1.43B. The returns ‎are nearly $456.03 million higher than the company’s actual revenue recorded in the fiscal year 2020. In ‎terms of EPS for the 2021, estimate put it at 0.74, higher than that of FY20 by $0.43. Estimates put this ‎year’s earnings growth at 138.70%, 51.40% for the next, and at an annual 50.00% over the next 5-year ‎period. As for sales, forecasts are for an increase of 46.80% in the current fiscal year and a further ‎‎30.20% over the following year.‎

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Havertys Furniture Companies Inc. (HVT) stock gains during after-hour trading, Here’s to know why?

Havertys Furniture Companies Inc. (NASDAQ: HVT) stock declined by 0.39% at last close whereas the HVT stock price gains by 4.6% in the after-hours...

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Flora Growth Corp. (FLGC) stock declines during premarket. Here’s what you should know?

Flora Growth Corp. (NASDAQ: FLGC) stock gained by 49.67% at last close whereas the FLGC stock price plunged by 18.36% in the pre-market trading...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Relmada Therapeutics Inc. (RLMD) stock is plunging in the current trading session; What’s going on?

In the current trading session, Relmada Therapeutics Inc. (RLMD) stock shares are plunging by -5.97%. The current trading price is at $23.62 in the...

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Tonix Pharmaceutics Holdings Inc. (TNXP) stock gains during current market. What’s driving it high?

Tonix Pharmaceuticals Holdings Inc. (TNXP) stock gains by 2.81% in the current market trading session. Tonix is a clinical-stage biopharmaceutical business dedicated on finding,...

Related News

Ocugen Inc. (NASDAQ:OCGN) stock plunged in the premarket trading session; here’s why

At last check Ocugen Inc. (OCGN) stock had plunged by-11.92% to $9.61 in premarket trading session. OCGN stock previously closed at $10.91 losing -12.79%....

KeyBanc reiterates Magna International [MGA] rating to Overweight and sets new price target at $86

KeyBanc maintained its Magna International rating to the equivalent of Overweight but changed the price target to $86.0 from $72, in a research...

Jefferies upgrades Medifast [MED] to Buy rating with a $265 price target

Jefferies took its Medifast rating to the equivalent of Buy from Hold, and the price target to $265.0 from $205, in a research...

American Eagle Outfitters [AEO] Upgraded to Outperform at RBC Capital

RBC Capital took its American Eagle Outfitters rating to the equivalent of Outperform from Sector Perform, and the price target to $30.0 from...

KeyBanc reiterates Nike [NKE] rating to Overweight and sets new price target at $180

KeyBanc maintained its Nike rating to the equivalent of Overweight but changed the price target to $180.0 from $174, in a research note...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam